Clonal Dynamics of the antibody response
抗体反应的克隆动力学
基本信息
- 批准号:10521309
- 负责人:
- 金额:$ 62.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAffinityAntibodiesAntibody AffinityAntibody ResponseAntibody titer measurementAntibody-Producing CellsAntibody-mediated protectionAntigensB-Cell ActivationB-Cell Antigen ReceptorB-LymphocytesBiologyBone MarrowCOVID-19 pandemicCell MaintenanceCellular biologyChronicClone CellsColorDataEffectivenessEpitopesFundingGoalsGrantHIVHepatitis C virusHomeImmune responseImmune systemImmunityImmunizationInfectionInfection ControlInfluenzaInfluenza HemagglutininInfluenza vaccinationInvestigationLaboratoriesLogicMapsMeasuresMemoryMemory B-LymphocyteMethodsModelingMolecularMutateMutationParabiosisPhasePlasma CellsPlasmablastPlayPopulationPropertyPublicationsReactionResearchRoleSARS-CoV-2 spike proteinSerumShapesSourceSpecificityStructureStructure of germinal center of lymph nodeSystemTestingTimeVaccinationVaccinesViralVirusVirus DiseasesWaxesWorkcross reactivitydesignimprintimprovedneutralizing antibodynovelpathogenplasma cell differentiationprotective efficacyresponseseasonal influenzastemtooluniversal vaccinevaccination strategy
项目摘要
PROJECT SUMMARY
Generating an appropriate antibody response is critical for protection against reinfection and for the effectiveness
of vaccination, particularly in the context of viral diseases. In addition to well-studied quantitative parameters
such as antibody titer and affinity, other, more qualitative parameters related to the clonal composition of the
response also play critical roles in antibody-mediated protection. These include antigen and epitope specificity,
which is key to viral neutralization capacity and antibody breadth, and overall clonal diversity, which strongly
influences the degree of immunodominance and therefore the ability of viruses to escape immunity by mutation.
Despite their importance, such “ecological” aspects of GC biology remain poorly understood and systematically
understudied at the mechanistic level.
Our long-term goal is to develop a mechanistic understanding of how the competitive waxing and waning of B
cell clones at the various stages of the immune response shapes the ultimate composition, specificity, and
protective efficacy of serum antibody. In our previous studies, using multicolor “Brainbow”-based B cell fate-
mapping models, we focused on the germinal center (GC) and memory phases of the response, revealing how
highly diverse early responders are funneled towards oligoclonality, first progressively by GC selection (including
in chronic gut-associated GC) and then dramatically by secondary boosting. We now propose to extend our work
using these same tools to investigate the clonal dynamics of prolonged selection in long-lived virus-induced GCs
(Aim 1) and of the progressive differentiation of plasmablasts and plasma cells from GC precursors (Aim 2). We
also propose a new “molecular fate-mapping” system to determine how clonal dynamics impact the ultimate
composition of serum antibody (Aim 3). This allows us to investigate the B cell biology of serum-level phenomena
such as antigenic imprinting/original antigenic sin, immunodominance, and viral escape.
We expect our findings will provide greater mechanistic understanding of how the composition and protective
effectiveness of serum antibody is determined by the dynamics of B cell clonal competition, with implications for
the design of effective vaccination strategies for influenza, HIV, and SARS-CoV-2.
项目摘要
产生适当的抗体反应对于防止再感染和有效地预防再感染至关重要。
接种疫苗,特别是在病毒性疾病的情况下。除了经过充分研究的定量参数外,
例如抗体滴度和亲和力,其它的,更多的与克隆组成相关的定性参数,
应答也在抗体介导的保护中起关键作用。这些包括抗原和表位特异性,
这是病毒中和能力和抗体宽度以及整体克隆多样性的关键,
影响免疫优势的程度,从而影响病毒通过突变逃避免疫的能力。
尽管它们的重要性,GC生物学的这些“生态”方面仍然知之甚少,
在机械层面上被忽视了。
我们的长期目标是对B的竞争力的消长有一个机械的理解
在免疫反应的各个阶段的细胞克隆形成了最终的组成,特异性,
血清抗体的保护效力。在我们之前的研究中,使用基于“Brainbow”的B细胞命运-
映射模型,我们专注于反应的生发中心(GC)和记忆阶段,揭示了如何
高度多样化的早期应答者向寡克隆性汇集,首先通过GC选择(包括
在慢性肠道相关GC中),然后通过二次加强显著增加。我们现在建议将我们的工作
使用这些相同的工具来研究长寿病毒诱导的GC中延长选择的克隆动态
(Aim 1)和浆母细胞和浆细胞从GC前体的进行性分化(目的2)。我们
还提出了一种新的“分子命运映射”系统来确定克隆动态如何影响最终
血清抗体组成(目的3)。这使我们能够研究血清水平现象的B细胞生物学
例如抗原印记/原始抗原印记、免疫显性和病毒逃逸。
我们希望我们的研究结果将提供更多的机械理解如何组成和保护
血清抗体的有效性是由B细胞克隆竞争的动力学决定的,其含义是:
设计针对流感、艾滋病毒和SARS-CoV-2的有效疫苗接种策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gabriel D Victora其他文献
Gabriel D Victora的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gabriel D Victora', 18)}}的其他基金
Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
通过细胞间酶标记定义 T 细胞在生发中心的作用
- 批准号:
10566601 - 财政年份:2022
- 资助金额:
$ 62.83万 - 项目类别:
Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
通过细胞间酶标记定义 T 细胞在生发中心的作用
- 批准号:
10708968 - 财政年份:2022
- 资助金额:
$ 62.83万 - 项目类别:
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
通过跨突触标记量化免疫系统中的细胞间相互作用
- 批准号:
10461008 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别:
Molecular control of germinal center selection and affinity maturation
生发中心选择和亲和力成熟的分子控制
- 批准号:
10212931 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别:
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
通过跨突触标记量化免疫系统中的细胞间相互作用
- 批准号:
10213593 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别:
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
通过跨突触标记量化免疫系统中的细胞间相互作用
- 批准号:
9980289 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别:
Molecular control of germinal center selection and affinity maturation
生发中心选择和亲和力成熟的分子控制
- 批准号:
9764262 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别:
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
通过跨突触标记量化免疫系统中的细胞间相互作用
- 批准号:
9768320 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别:
Molecular control of germinal center selection and affinity maturation
生发中心选择和亲和力成熟的分子控制
- 批准号:
9977119 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别:
Molecular control of germinal center selection and affinity maturation
生发中心选择和亲和力成熟的分子控制
- 批准号:
10463638 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别:
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 62.83万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 62.83万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 62.83万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 62.83万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 62.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 62.83万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 62.83万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 62.83万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 62.83万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 62.83万 - 项目类别: